JPS51149291A - Preparation method of imidazolinylaminoquinoxaline and quinazolines - Google Patents

Preparation method of imidazolinylaminoquinoxaline and quinazolines

Info

Publication number
JPS51149291A
JPS51149291A JP50105862A JP10586275A JPS51149291A JP S51149291 A JPS51149291 A JP S51149291A JP 50105862 A JP50105862 A JP 50105862A JP 10586275 A JP10586275 A JP 10586275A JP S51149291 A JPS51149291 A JP S51149291A
Authority
JP
Japan
Prior art keywords
imidazolinylaminoquinoxaline
quinazolines
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50105862A
Other languages
Japanese (ja)
Inventor
Baarii Toomasu Maikeru
Torebirian Uiriamusu Maikeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS51149291A publication Critical patent/JPS51149291A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
JP50105862A 1974-09-06 1975-09-01 Preparation method of imidazolinylaminoquinoxaline and quinazolines Pending JPS51149291A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3914374A GB1463520A (en) 1974-09-06 1974-09-06 Process for the production of imidazolines

Publications (1)

Publication Number Publication Date
JPS51149291A true JPS51149291A (en) 1976-12-22

Family

ID=10407882

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50105862A Pending JPS51149291A (en) 1974-09-06 1975-09-01 Preparation method of imidazolinylaminoquinoxaline and quinazolines

Country Status (12)

Country Link
JP (1) JPS51149291A (en)
BE (1) BE833135A (en)
CA (1) CA1043791A (en)
DE (1) DE2538620A1 (en)
DK (1) DK398775A (en)
ES (1) ES440760A1 (en)
FI (1) FI752487A (en)
FR (1) FR2283899A1 (en)
GB (1) GB1463520A (en)
LU (1) LU73327A1 (en)
NL (1) NL7510473A (en)
SE (1) SE7509271L (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015124205A (en) * 2013-12-27 2015-07-06 カズマパートナーズ株式会社 Amorphous brimonidine tartrate and method for producing the same
JP2015203011A (en) * 2014-04-14 2015-11-16 カズマパートナーズ株式会社 Novel polymorph of brimonidine tartrate and production method thereof

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077292A (en) * 1989-10-12 1991-12-31 Allergan, Inc. (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
US5198442A (en) * 1989-10-12 1993-03-30 Allergan, Inc. (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
US5326763A (en) * 1989-10-12 1994-07-05 Allergan, Inc. Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
US5204347A (en) * 1989-10-12 1993-04-20 Allergan, Inc. Methods for using (2-imidazolin-2-ylamino) tetrahydroquinoxalines
US5112822A (en) * 1989-10-12 1992-05-12 Allergan, Inc. (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same
US5021416A (en) * 1989-10-31 1991-06-04 Allergan, Inc. Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
US5237072A (en) * 1990-02-06 1993-08-17 Allergan, Inc. Method for producing amino-2-imidazoline derivatives
US5130441A (en) * 1990-02-06 1992-07-14 Allergan, Inc. Method for producing amino-2-imidazoline derivatives
US6323204B1 (en) 1993-10-13 2001-11-27 Allergan Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
EP0723447B1 (en) * 1993-10-13 2002-12-11 Allergan, Inc. Use of (2-imidazolin-2-ylamino) quinoxaline derivatives
CA2505836C (en) 2004-05-06 2013-08-27 Alcon Inc. Topical brimonidine tartrate formulations that lack chlorine dioxide
ES2818073T3 (en) 2013-12-24 2021-04-09 Sentiss Pharma Private Ltd Topical Brimonidine Tartrate Ophthalmic Solution
EP4142689A1 (en) 2020-04-29 2023-03-08 Sentiss Pharma Private Limited Ophthalmic compositions comprising a combination of brinzolamide and brimonidine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4897878A (en) * 1972-02-29 1973-12-13

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4897878A (en) * 1972-02-29 1973-12-13

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015124205A (en) * 2013-12-27 2015-07-06 カズマパートナーズ株式会社 Amorphous brimonidine tartrate and method for producing the same
JP2015203011A (en) * 2014-04-14 2015-11-16 カズマパートナーズ株式会社 Novel polymorph of brimonidine tartrate and production method thereof

Also Published As

Publication number Publication date
BE833135A (en) 1976-03-05
SE7509271L (en) 1975-12-29
LU73327A1 (en) 1977-05-11
GB1463520A (en) 1977-02-02
DE2538620A1 (en) 1976-03-18
AU8430575A (en) 1977-03-03
CA1043791A (en) 1978-12-05
FR2283899A1 (en) 1976-04-02
DK398775A (en) 1976-03-07
FI752487A (en) 1976-03-07
NL7510473A (en) 1976-03-09
ES440760A1 (en) 1977-04-01

Similar Documents

Publication Publication Date Title
HK73179A (en) Semiconductor structures and methods of making them
CS181182B2 (en) Vehiculum of medicament and method of its produce
JPS51112455A (en) Connected structure and method of connecting same
JPS5389565A (en) Chair and method of producing same
ZA757481B (en) New antihypertensive compounds and method of preparing same
JPS5215955A (en) Multiivvpulley and method of producing same
JPS51119305A (en) Bricket and method of producing same
JPS51149291A (en) Preparation method of imidazolinylaminoquinoxaline and quinazolines
JPS51128343A (en) Selfflubrication heattresisting materials and method of manufacture
IL46580A0 (en) Self-adhesive tiles for dry-tiling and method of preparing the same
IL46917A0 (en) The preparation of 2-nitrobenzaldehyde and 2-nitrobenzylidenechloride
ZA753849B (en) Transfer elements and method of preparing same
JPS5219623A (en) Nitryle and method of its preparation
JPS5511599A (en) Method of inproving*enhancing and modifying functional characteristics
ZA753247B (en) (d1)-13-substituted sulfinyl-prostaglandinlike compounds and methods of making
ZA75416B (en) Ureidotetralin compounds and method of use
ZA753963B (en) Hydrodesuphurisation catalyst and method of manufacture and use thereof
IL48565A (en) Method of preparation of 3-methylene-cephams and novel 3-methyl-2-(2-sulfino-4-oxo-3-acylamino-1-azetidinyl)-3-butenoates
JPS532401A (en) Antibioticsaa3551 and method of preparation thereof
JPS5212183A (en) Preparation method of quinazolines
GR58472B (en) Pseudotrisacharites and process of their preparation
NZ178105A (en) Preparation of 11 -hydroxy-18-alkylestranes and intermediates therein
ZA754550B (en) Method of using 4-biphenylethanol and 4-biphenylacetaldehyde
PH11024A (en) Substituted triazinobenzimidazoles and method of use thereof
CH614216A5 (en) Process for the preparation of deoxyparomomycin and dideoxyparomomycin